by Peace Chukwu | Jul 6, 2023
Imagine slowly losing control of your body and the muscles necessary to live healthily, until you eventually lose your ability to breathe. This disease is known as Amyotrophic lateral sclerosis, or ALS, and is caused by the degeneration of motor neurons that send...
by Kevin Robb | Jun 29, 2023
Mesenchymal stromal cells (MSCs) have been at the front line of cell therapy and regenerative medicine efforts for decades. Investigators hotly pursued MSCs as prospective cell therapies for a wide range of diseases, but enthusiasts were left wanting when several...
by Sara M. Nolte | Jun 21, 2023
In addition to showers, flowers and warmer weather, this spring also brought renewed hope for patients with hematological malignancies undergoing stem cell transplants (SCTs) in the form of the approval of Gamida Cell’s Omisirge® (omidubicel). This cell-based therapy...
by Don Gibbons | May 25, 2023
A recent Wall Street Journal article reminded me of the work of someone I came to know well while at the California Institute for Regenerative Medicine (CIRM): Jeanne Loring of the Scripps Research Institute. The article detailed a cell therapy for Parkinson’s Disease...
by Don Gibbons | May 4, 2023
For people like me working in the biological science sector, the annual DNA Day (every April 25th) is always a cause to raise a toast, but this year was special. It marked the 70th anniversary of the discovery of the double helix by Watson and Crick (and Franklin) and...
by Sara M. Nolte | Apr 18, 2023
One of the major limitations of using stem cell donors is the challenge of finding an adequate match, which is why I always get excited about therapies that use a patient’s own tissue. But why is the issue of a “match” such a big deal? You may have come across terms...
Comments